TY - JOUR
T1 - Patient-reported experience of dry eye management
T2 - An international multicentre survey
AU - Bilkhu, Paramdeep
AU - Sivardeen, Zimar
AU - Chen, Connie
AU - Craig, Jennifer P
AU - Mann, Kylie
AU - Wang, Michael T M
AU - Jivraj, Saleel
AU - Mohamed-Noriega, Karim
AU - Charles-Cantú, David E
AU - Wolffsohn, James S
N1 - © 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Purpose: To explore the journey taken by patients in a range of different countries to manage their dry eye symptoms. Method: Members of the general public who responded positively to the question “Do your eyes ever feel dry?” completed a questionnaire describing their demographics, the impact of their symptomology, the advice they have received and the management options they have tried. The Ocular Surface Disease Index (OSDI) questionnaire was also completed. Results: A total of 916 individuals (Canada = 235, Mexico = 127, New Zealand = 157, Taiwan = 246, UK = 151) of similar age distribution (median 38 years, IQR: 27–50) completed the survey. The reported duration of symptoms was longest in Canada (median 4 years, range 2–10) and least in Taiwan (2 years, range 1–3; p < 0.001), and similar trends were observed for symptom severity (p = 0.001). However, there was no statistically significant difference between countries with respect to the impact of symptoms on quality of life (median 3/10; p = 0.08). Less than half of the individuals in any country had consulted with a health professional. About half had tried a treatment for their dry eye symptoms, with artificial tears being the most common treatment, followed by warm compresses, and both therapies were rated as reasonably effective (median 5−7/10). Conclusion: Many people with dry eye symptoms are not consulting health care professionals who can confirm the diagnosis, exclude differential diagnoses, and offer a wide range of treatments targeted at the dry eye subtype.
AB - Purpose: To explore the journey taken by patients in a range of different countries to manage their dry eye symptoms. Method: Members of the general public who responded positively to the question “Do your eyes ever feel dry?” completed a questionnaire describing their demographics, the impact of their symptomology, the advice they have received and the management options they have tried. The Ocular Surface Disease Index (OSDI) questionnaire was also completed. Results: A total of 916 individuals (Canada = 235, Mexico = 127, New Zealand = 157, Taiwan = 246, UK = 151) of similar age distribution (median 38 years, IQR: 27–50) completed the survey. The reported duration of symptoms was longest in Canada (median 4 years, range 2–10) and least in Taiwan (2 years, range 1–3; p < 0.001), and similar trends were observed for symptom severity (p = 0.001). However, there was no statistically significant difference between countries with respect to the impact of symptoms on quality of life (median 3/10; p = 0.08). Less than half of the individuals in any country had consulted with a health professional. About half had tried a treatment for their dry eye symptoms, with artificial tears being the most common treatment, followed by warm compresses, and both therapies were rated as reasonably effective (median 5−7/10). Conclusion: Many people with dry eye symptoms are not consulting health care professionals who can confirm the diagnosis, exclude differential diagnoses, and offer a wide range of treatments targeted at the dry eye subtype.
KW - Artificial tears
KW - Dry eye
KW - Over the counter medication
KW - Patient-reported experience
UR - https://www.sciencedirect.com/science/article/pii/S1367048421000618?via%3Dihub
UR - http://www.scopus.com/inward/record.url?scp=85105071947&partnerID=8YFLogxK
U2 - 10.1016/j.clae.2021.101450
DO - 10.1016/j.clae.2021.101450
M3 - Article
C2 - 33941501
SN - 1367-0484
VL - 45
JO - Contact Lens and Anterior Eye
JF - Contact Lens and Anterior Eye
IS - 1
M1 - 101450
ER -